Form 8-K - Current report:
SEC Accession No. 0001493152-24-042741
Filing Date
2024-10-29
Accepted
2024-10-28 17:54:37
Documents
15
Period of Report
2024-10-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 61098
2 ex10-85.htm EX-10.85 27014
3 ex10-86.htm EX-10.86 37039
  Complete submission text file 0001493152-24-042741.txt   316397

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bixt-20241025.xsd EX-101.SCH 3085
5 XBRL LABEL FILE bixt-20241025_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE bixt-20241025_pre.xml EX-101.PRE 24173
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3559
Mailing Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494
Business Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

EIN.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35027 | Film No.: 241402147
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)